Abstract-Disorders of the maternal-placental-fetal unit often results in fetal brain injury, which in turn results in one of the highest burdens of disease, because of the lifelong consequences and cost to society. Investigating hypoxia-ischemia in the perinatal period requires the factoring of timing of the insult, determination of end-points, taking into account the innate development, plasticity, and enhanced recovery. Prenatal hypoxia-ischemia is believed to account for a majority of cerebral palsy cases. We have modeled sustained and repetitive hypoxia-ischemia in the pregnant rabbit in utero to mimic the insults of abruptio placenta and labor, respectively. Rabbits have many advantages over other animal species; principally, their motor development is in the perinatal period, akin to humans. Sustained hypoxia-ischemia at 70% (E22) and 79% (E25) caused stillbirths and multiple deficits in the postnatal survivors. The deficits included impairment in multiple tests of spontaneous locomotion, reflex motor activity, motor responses to olfactory stimuli, and the coordination of suck and swallow. Hypertonia was observed in the E22 and E25 survivors and persisted for at least 11 days. Noninvasive imaging using MRI suggests that white matter injury in the internal capsule could explain some of the hypertonia. Further investigation is underway in other vulnerable regions such as the basal ganglia, thalamus and brain stem, and development of other noninvasive determinants of motor deficits. erebral palsy is a nonprogressive disorder of the developing brain principally affecting the motor system. Cerebral palsy affects 2 to 3 per 1000 newborns, with a conservative estimate of its impact on society being Ϸ$5 billion per year. Cerebral palsy can be associated with epilepsy and abnormalities of speech, vision, and intellect. The impact of diseases affecting the newborn are much higher than diseases that affect the elderly because of the burden of disease when one considers mortality, years of life lost, and years of productive life lost. If one compares the economic impact of disease of an elderly person at the end of life compared with that of disease of a fetus or baby, the impact of the latter is far more. Lifetime costs for all persons of cerebral palsy are estimated to total $11.5 billion. 1 These costs underscore the need to urgently develop preventive and secondary therapeutic measures for the fetus and newborn. Little progress has been made over the past few decades on the prevalence of cerebral palsy. [2][3][4] The lack of development of new therapies has been partly because of the malpractice climate in United States. 5 Progress is also slow because of the unique obstacles facing investigators studying brain injury in the perinatal period, principally related to the issue of timing. 6 During the progression of neurological development, the timing of the insult and of end points becomes crucial in any study. The investigator has to take into account not only the plasticity of the stage of development but also th...